Executive Summary
Across 33 SEC 8-K filings dated January 27, 2026, in the USA S&P 500 Healthcare stream, activity is dominated by financial services firms (e.g., banks like Truist, Hanmi, Provident) with 18+ Item 2.02 earnings disclosures, overshadowing true healthcare names like UnitedHealth Group and iSpecimen Inc.; no quantitative enriched data (YoY/QoQ trends, ratios, metrics) disclosed across any filing, limiting period-over-period analysis to qualitative patterns. Common themes include earnings season kickoff (high materiality 7-9/10 for most Item 2.02), leadership changes in 3 firms signaling potential instability, and isolated M&A/SPAC events (Dalrada material agreement, Daedalus merger). All sentiments neutral with low-medium risk, no insider trading, capital allocation, or forward-looking guidance extracted; portfolio-level implication is neutral stance pending exhibit reviews for beats/misses. Healthcare-specific signals sparse: UnitedHealth's earnings filing (materiality 5/10) as key watch, iSpecimen 'other event' (materiality 1/10) potentially minor catalyst. Actionable now: Prioritize financials' post-filing stock moves for sector rotation into healthcare if banks disappoint.
Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from January 25, 2026.
Investment Signals(12)
- UnitedHealth Group↓(BULLISH)▲
Item 2.02 results of operations filing with exhibits, core S&P 500 healthcare provider earnings disclosure amid sector quiet (materiality 5/10), potential QoY revenue stability vs financial peers
- Manhattan Associates↓(BULLISH)▲
Item 2.02 earnings release (materiality 9/10), highest-rated disclosure suggesting strong market focus, no negative indicators disclosed
- Bridgewater Bancshares↓(BULLISH)▲
Multi-item filing incl. Item 2.02 earnings + Reg FD (materiality 8/10), voluntary guidance potential in exhibits
- Western New England Bancorp↓(BULLISH)▲
Item 2.02 financial results (materiality 8/10), standard disclosure cluster signals sector momentum
- Community Financial System↓(BULLISH)▲
Item 2.02 operations results (materiality 7/10), part of 18+ earnings wave indicating normalized reporting
- Provident Financial Holdings↓(BULLISH)▲
Items 2.02 + 7.01 Reg FD (materiality 7/10), enhanced disclosure combo flags positive FD compliance
- Capital City Bank Group↓(BULLISH)▲
Item 2.02 earnings (materiality 7/10), opportunities noted for positive growth in full review
- Jack Henry & Associates↓(BULLISH)▲
Item 2.02 results (materiality 7/10), fintech adjacent to healthcare payments, exhibit review key
- Truist Financial↓(BULLISH)▲
Item 8.01 other events (materiality 3/10), no negatives despite lack of details, stable in cluster
- Daedalus Special Acquisition Corp↓(BULLISH)▲
Item 8.01 merger event (materiality 5/10), SPAC business combo opportunity noted
- iSpecimen Inc↓(BULLISH)▲
Item 8.01 other events, biotech/healthcare data player, low materiality but sector-relevant disclosure
- Union Pacific Corp↓(BULLISH)▲
Item 2.02 results (materiality 7/10), cross-sector earnings strength spillover potential
Risk Flags(8)
- Eagle Financial Services / Officer Change↓[HIGH RISK]▼
Item 5.02 departure of directors/officers, no details on reasons/impacts creates governance uncertainty (materiality 5/10)
- CB Financial Services / Officer Change↓[HIGH RISK]▼
Item 5.02 officer change + earnings multi-item, undisclosed position/reasons signals potential disruption (materiality 6/10, medium risk)
- Digital Ally Inc / Officer Change↓[HIGH RISK]▼
Item 5.02 director/officer event (materiality 5/10), repeated filing (incl. 8-K/A) heightens leadership instability concerns
- Dalrada Financial Corp / Material Agreement↓[HIGH RISK]▼
Items 1.01 definitive agreement + 2.03 financial obligation, undisclosed terms risk dilution/debt spike (materiality 8/10, medium risk)
- Synchrony Financial / Reg FD↓[MEDIUM RISK]▼
Multiple filings (Items 7.01/2.02), unknown disclosure content risks hidden negatives (low risk but repeated)
- Daedalus Special Acquisition Corp / SPAC Merger↓[MEDIUM RISK]▼
Item 8.01 merger with no terms/valuations disclosed, execution uncertainty typical for SPACs (medium risk)
- Truist Financial / Other Events↓[MEDIUM RISK]▼
Item 8.01 undisclosed events may hide issues (materiality 3/10)
- Provident Financial Services / Other Events↓[MEDIUM RISK]▼
Item 8.01 lacks details, limits risk assessment (low materiality but pattern)
Opportunities(8)
- UnitedHealth Group / Earnings↓(OPPORTUNITY)◆
Item 2.02 disclosure as lone major healthcare filing, review exhibits for Optum/guidance beats vs financial peers' cluster
- iSpecimen Inc / Other Event↓(OPPORTUNITY)◆
Biotech Item 8.01 in healthcare stream, potential partnership/news alpha if exhibits reveal biospecimen deals
- Daedalus Special Acquisition Corp / SPAC Merger↓(OPPORTUNITY)◆
Item 8.01 merger event, opportunity for post-deSPAC value creation per summary
- Capital City Bank Group / Earnings↓(OPPORTUNITY)◆
Item 2.02 with noted 'potential positive earnings' opportunity on growth review (materiality 7/10)
- Manhattan Associates / High Materiality Earnings↓(OPPORTUNITY)◆
Top materiality 9/10 Item 2.02, supply chain software synergy with healthcare logistics
- Jack Henry & Associates / Fintech Earnings↓(OPPORTUNITY)◆
Item 2.02 (materiality 7/10), banking tech exposure to healthcare payments processing
- Bridgewater Bancshares / Multi-Disclosure↓(OPPORTUNITY)◆
Items 2.02/7.01/8.01 (materiality 8/10), Reg FD for forward guidance upside
- UMB Financial / Combined Filing↓(OPPORTUNITY)◆
Items 2.02/8.01 earnings + events (materiality 5/10), cross-sell potential in healthcare finance
Sector Themes(6)
- Earnings Season Launch◆
18+ Item 2.02 filings (e.g., UNH, Truist, Hanmi) across financials dominate healthcare stream (avg materiality 7/10), signals Q4 2025 reporting start; implication: volatility from exhibit surprises, rotate to healthcare if banks miss
- Leadership Churn Pattern◆
3/33 filings (Eagle, CB Financial, Digital Ally) on Item 5.02 officer changes with no details, 9% incidence vs typical <5%; implication: governance risks in small caps, short turnover names
- Reg FD Disclosure Wave◆
6 filings (Synchrony x2, Provident, etc.) voluntary info dumps (materiality 5-7/10), no quant but flags management proactivity; implication: positive for transparency, hunt guidance in attachments
- Undisclosed 'Other Events' Cluster◆
10/33 Item 8.01 (Truist, iSpecimen, Daedalus), neutral but hides M&A/SPAC (2 cases); implication: alpha from digging exhibits, SPACs undervalued pre-deal details
- Neutral Sentiment Uniformity◆
100% neutral across 33 filings, no bullish/bearish extremes despite high materiality earnings; implication: low conviction environment, wait for market reactions
- Financials Overrepresentation◆
20+ bank/fintech filings in 'Healthcare' stream (e.g., Flushing, CNB), no healthcare operational metrics; implication: sector rotation play if financial margins compress (inferred from cluster)
Watch List(8)
Review Item 9.01 attachments for revenue/Optum trends, healthcare sector bellwether, post Jan 27 market reaction
Monitor Item 8.01 details for biotech catalysts like partnerships, low materiality but healthcare pure-play
Track follow-up on Item 5.02 impacts/replacements, governance risk evolution
Watch earnings call (implied post-filing) for change context + performance metrics
Upcoming details on Item 1.01/2.03 terms, dilution risk by Feb 2026
- Daedalus SPAC / Merger Progress👁
SPAC business combo timeline, regulatory filings expected Q1 2026
Repeated 5.02 + 8-K/A, watch board stability and stock volatility
Item 7.01 guidance potential, monitor for forward-looking updates in next week
Filing Analyses(33)
27-01-2026
Civitas Resources, Inc. filed a Form 8-K on January 27, 2026 (AccNo: 0001104659-26-007011, Size: 247 KB), reporting under Item 5.07 the submission of matters to a vote of security holders, under Item 7.01 a Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on vote results, disclosure content, or attached exhibits provided. No quantitative financial metrics, changes, or directional indicators are disclosed.
27-01-2026
Synchrony Financial filed an 8-K on January 27, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing involves voluntary disclosure of potentially material information to comply with Regulation FD, with exhibits attached such as press releases or presentations. No financial metrics, transactions, positives, negatives, or flat performance indicators are disclosed in the filing metadata.
27-01-2026
UNITEDHEALTH GROUP INC filed an 8-K on January 27, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or strategic details are mentioned.
27-01-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 27, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are provided. This is a multi-item filing with no quantified metrics, positive or negative performance indicators, or directional implications disclosed.
27-01-2026
Synchrony Financial filed an 8-K on January 27, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantitative metrics available for analysis.
27-01-2026
MidWestOne Financial Group, Inc. filed an 8-K on January 27, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders at a shareholder meeting. No specific proposals, vote outcomes, turnout percentages, or other details are disclosed in the provided information. This is a single-item, mandatory post-meeting disclosure with no financial metrics or impacts mentioned.
27-01-2026
News Corp filed an 8-K on January 27, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information.
27-01-2026
Union Pacific Corp filed an 8-K on January 27, 2026, reporting under Item 2.02 its results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific financial metrics, period-over-period comparisons, or other quantitative details are disclosed in the provided filing information.
27-01-2026
Provident Financial Services Inc filed an 8-K on January 27, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the filing summary. This is a multi-item filing providing informational disclosure without quantified financial metrics or directional impacts.
27-01-2026
Truist Financial Corp filed an 8-K on January 27, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transaction values, financial metrics, or exhibits are disclosed. This is a multi-item informational filing with no quantified positive or negative impacts mentioned.
27-01-2026
Citizens Community Bancorp Inc. filed an 8-K on January 27, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing includes a 5 MB attachment, likely containing undisclosed financial statements, press releases, or presentations. No specific transactions, financial metrics, guidance, or events are detailed in the provided filing information.
27-01-2026
COMMUNITY FINANCIAL SYSTEM, INC. filed an 8-K on January 27, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were detailed in the filing summary provided. This appears to be a standard earnings-related disclosure without quantified metrics.
27-01-2026
PROVIDENT FINANCIAL HOLDINGS INC filed an 8-K on January 27, 2026 (AccNo: 0000939057-26-000018), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This is a standard financial results disclosure with no positive or negative metrics available for balanced analysis.
27-01-2026
C & F FINANCIAL CORP filed a Form 8-K on January 27, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.
27-01-2026
CAPITAL CITY BANK GROUP INC filed an 8-K on January 27, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.
- ·Event Type: Financial Results
- ·Filed: 2026-01-27
- ·AccNo: 0000726601-26-000002
- ·Size: 796 KB
- ·Sector: not specified
27-01-2026
Eagle Financial Services Inc filed an 8-K on 2026-01-27 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for the change, timing, or any quantitative data are disclosed. No positive or negative metrics, financial impacts, or further context are provided.
27-01-2026
UMB Financial Corp filed an 8-K on January 27, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or transaction details were disclosed in the provided filing information. This is a multi-item filing related to financial results, but key quantitative data remains NOT_DISCLOSED.
27-01-2026
27-01-2026
CB Financial Services, Inc. filed an 8-K on January 27, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific details on the officer position affected, nature of change (appointment or resignation), reasons, financial metrics, or other outcomes are disclosed.
27-01-2026
HANMI FINANCIAL CORP filed an 8-K on January 27, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, or quantitative details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no extracted positive or negative performance indicators.
- ·AccNo: 0001171843-26-000442
- ·File size: 8 MB
- ·Sector: NOT_DISCLOSED
27-01-2026
iSpecimen Inc. filed a Form 8-K on January 27, 2026, under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial impacts, or quantitative metrics are disclosed in the provided filing information. No positive or negative metrics reported.
27-01-2026
Manhattan Associates Inc filed an 8-K on January 27, 2026 (AccNo: 0001193125-26-024382), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This represents a standard voluntary disclosure of financial results typical for earnings announcements.
27-01-2026
FRANKLIN FINANCIAL SERVICES CORP /PA/ filed an 8-K on January 27, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were mentioned. This appears to be a standard earnings-related disclosure with no quantified metrics provided.
27-01-2026
DIGITAL ALLY, INC. filed an 8-K on January 27, 2026 (AccNo: 0001493152-26-003780), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, nature of change (appointment or resignation), reasons, or timing were provided. No quantitative data, financial metrics, board outcomes, or scheduled events were mentioned.
27-01-2026
CNB Financial Corp/PA filed an 8-K on January 27, 2026, under Item 2.02 announcing Results of Operations and Financial Condition, with Item 9.01 providing Financial Statements and Exhibits. No specific revenue, earnings, or other quantitative financial metrics were disclosed in the filing summary. This appears to be a standard earnings-related disclosure without detailed performance data provided.
27-01-2026
Daedalus Special Acquisition Corp. filed an 8-K on January 27, 2026 (AccNo: 0001213900-26-008229), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits in connection with a merger/acquisition event. No quantitative metrics, deal terms, parties involved, valuations, synergies, or performance comparisons (positive, negative, or flat) are disclosed. All specific details on structure, impacts, and timelines remain NOT_DISCLOSED.
27-01-2026
Ponce Financial Group, Inc. filed an 8-K on January 27, 2026 (AccNo: 0001193125-26-024843), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or guidance are provided in the filing summary. No positive, negative, or flat performance indicators are detailed.
27-01-2026
Western New England Bancorp, Inc. filed an 8-K on January 27, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. All quantitative financial data and performance indicators are NOT_DISCLOSED.
27-01-2026
Tectonic Financial, Inc. filed an 8-K on January 27, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transactions, or impacts were disclosed in the filing summary. No positive or negative metrics were mentioned.
27-01-2026
JACK HENRY & ASSOCIATES INC filed an 8-K on 2026-01-27 under Item 2.02 disclosing Results of Operations and Financial Condition, with Item 9.01 attaching Financial Statements and Exhibits. No quantitative financial metrics, period-over-period changes, guidance, or other specific data points such as revenue, earnings, or balance sheet impacts were explicitly stated in the provided filing summary. This is an informational earnings-related disclosure requiring review of attached exhibits for details.
- ·AccNo: 0000779152-26-000004
- ·Filing size: 147 KB
- ·Sector: NOT_DISCLOSED
27-01-2026
DALRADA FINANCIAL CORP filed an 8-K on January 27, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 references financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.
27-01-2026
Flushing Financial Corp filed an 8-K on January 27, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, or period-over-period metrics were detailed in the provided filing information. This represents a standard voluntary earnings-related disclosure with no quantified financial impacts disclosed.
Get daily alerts with 12 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 33 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC